8.1.2021   

EN

Official Journal of the European Union

C 6/13


Summary of European Union decisions on marketing authorisations in respect of medicinal products from 6 January 2021 to 6 January 2021

(Published pursuant to Article 13 or Article 38 of Regulation (EC) No 726/2004 of the European Parliament and of the Council (1) )

(2021/C 6/11)

—

Issuing of a marketing authorisation (Article 13 of Regulation (EC) No 726/2004 of the European Parliament and of the Council): Accepted

Date of the decision

Name of the medicinal product

INN (International Non-Proprietary Name)

Holder of the marketing authorisation

Number of the entry in the Community Register

Pharmaceutical form

ATC code (Anatomical Therapeutic Chemical Code)

Date of notification

6.1.2021

COVID-19 Vaccine Moderna

COVID-19 mRNA Vaccine (nucleoside modified)

MODERNA BIOTECH SPAIN, S.L. Calle Monte Esquinza 30, 28010 Madrid, España

EU/1/20/1507

dispersion for injection

J07BX

6.1.2021

Anyone wishing to consult the public assessment report on the medicinal products in question and the decisions relating thereto is invited to contact:

European Medicines Agency

Domenico Scarlattilaan 6

1083 HS Amsterdam

NETHERLANDS


(1)  OJ L 136, 30.4.2004, p. 1.